Numerous interventional studies in animal models of diabetes and/or obesity have shown that the exogenous administration of recombinant irisin can restore glucose and lipid homeostasis and exert anti-diabetic and anti-obesity effects [221]. This evidence concerns the gene FNDC5 and obesity disorder.